Development of Plasma Marker Signature and Neuronprotective Drugs for Predicting and Preventing Brain Damage in Cardiogenic Extracorporeal Membrane Oxygenation Patients

2019-08-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/690852葉克膜腦神經損傷血清標誌特徵甲基化基因藥物篩選extracorporeal membrane oxygenation (ECMO)cerebral neuronal injuryplasma marker signaturegene methylationdrug screeningDevelopment of Plasma Marker Signature and Neuronprotective Drugs for Predicting and Preventing Brain Damage in Cardiogenic Extracorporeal Membrane Oxygenation Patients